(Q38010013)

26 August 2017

title

Uric acid in heart failure: a biomarker or therapeutic target? (English)

1 reference

26 August 2017

0 references

0 references

2

1 reference

26 August 2017

Marc Kaufman

1

1 reference

26 August 2017

publication date

1 March 2013

1 reference

26 August 2017

published in

Heart Failure Reviews

1 reference

26 August 2017

volume

18

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

177-186

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-012-9322-2

26 August 2017

exact match

0 references

cites work

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Serum uric acid levels as a predictor of in-hospital death in patients hospitalized for decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricemia and incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Diagnostic and prognostic value of uric acid in patients with acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Absence of xanthine oxidoreductase activity in human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

The paradoxical relationship between serum uric acid and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

The influence of the extracellular fluid volume on the tubular reabsorption of uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Effect of serum insulin on the association between hyperuricemia and incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric acid and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Factors affecting urate excretion following diuretic administration in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Serum uric acid levels correlate with left atrial function and systolic right ventricular function in patients with newly diagnosed heart failure: the hellenic heart failure study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricemia as a prognostic factor in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol improves endothelial dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Allopurinol and global left myocardial function in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Impact of allopurinol use on urate concentration and cardiovascular outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Enhanced Expression and Activity of Xanthine Oxidoreductase in the Failing Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricaemia in patients with right or left heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9322-2

Hyperuricemia in acute heart failure. More than a simple spectator?

21 January 2018

1 reference

12 December 2020

Serum uric acid levels correlate with filling pressures in systolic heart failure

1 reference

12 December 2020

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study

1 reference

12 December 2020

Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?

1 reference

12 December 2020

Role of angiotensin II and the sympathetic nervous system in the control of renal function

1 reference

12 December 2020

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study

1 reference

12 December 2020

Uric acid in chronic heart failure--current pathophysiological concepts

1 reference

12 December 2020

The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure

1 reference

12 December 2020

Hyperuricemia; relationship to hypercholesteremia and acute myocardial infarction

1 reference

12 December 2020

The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study

1 reference

12 December 2020

Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis

1 reference

12 December 2020

Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters.

1 reference

12 December 2020

Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study

1 reference

12 December 2020

The reduction of cytochrome c by milk xanthine oxidase

1 reference

12 December 2020

Uric acid and cardiovascular risk

1 reference

12 December 2020

Hyperuricemia predicts adverse outcomes in patients with heart failure

1 reference

12 December 2020

Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure

1 reference

12 December 2020

Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients

1 reference

12 December 2020

Uric acid in chronic heart failure: a marker of chronic inflammation

1 reference

12 December 2020

Serum uric acid in relation to age and physique in health and in coronary heart disease

1 reference

12 December 2020

Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men

1 reference

12 December 2020

10.1007/S10741-012-9322-2

Identifiers

DOI

1 reference

26 August 2017

1 reference